357 results
Page 5 of 18
DFRN14A
dxeck2gps
4 Nov 20
Revised proxy by non-management
4:09pm
DEFC14A
8w9ecb5du3lui
2 Nov 20
Proxy in contested solicitation
8:34am
DEFC14A
7j9wl2863248p0nr
30 Oct 20
Proxy in contested solicitation
4:46pm
PRRN14A
smta r1l1f
29 Oct 20
Revised preliminary proxy statement filed by non-management
4:48pm
PRRN14A
pzl5o7
28 Oct 20
Revised preliminary proxy statement filed by non-management
5:20pm
UPLOAD
eub31t7zupmtw
28 Oct 20
Letter from SEC
12:00am
PRER14A
ucl8sa80 x1z7
27 Oct 20
Preliminary revised proxy
4:14pm
UPLOAD
wdog4encnt
27 Oct 20
Letter from SEC
12:00am
PRRN14A
9mefbl6o wetfj
26 Oct 20
Revised preliminary proxy statement filed by non-management
5:27pm
UPLOAD
1cy5rzyg44bszhs3m4
22 Oct 20
Letter from SEC
12:00am
PREC14A
zeq8xtb79u e2xytp71
21 Oct 20
Preliminary proxy with contested solicitation
5:14pm
PREC14A
w806prfj yxzzs79ej
16 Oct 20
Preliminary proxy with contested solicitation
12:49pm
8-K
EX-3.1
qw2jnjmajq
22 Sep 20
Ziopharm Oncology Appoints Kevin Buchi to its Board of Directors
8:46am
8-K
EX-10.1
df4978f
29 May 20
Ziopharm Oncology Presents Encouraging Clinical Data for ControlledIL-12 for the Treatment of Recurrent Glioblastoma
8:16am